| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
38,521 |
33,944 |
$5.31M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
29,420 |
25,539 |
$4.32M |
| 71045 |
Radiologic examination, chest; single view |
8,473 |
7,136 |
$1.21M |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
8,432 |
6,946 |
$1.19M |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
8,118 |
7,283 |
$1.04M |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
10,671 |
8,724 |
$760K |
| 41899 |
Unlisted procedure, dentoalveolar structures |
371 |
337 |
$754K |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
6,432 |
5,415 |
$594K |
| 71046 |
Radiologic examination, chest; 2 views |
6,611 |
5,681 |
$529K |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
8,497 |
7,332 |
$524K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
15,879 |
13,356 |
$259K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
597 |
499 |
$212K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
1,840 |
1,690 |
$211K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
46,227 |
38,878 |
$185K |
| 66984 |
Extracapsular cataract removal with insertion of intraocular lens prosthesis |
57 |
38 |
$164K |
| 80053 |
Comprehensive metabolic panel |
27,023 |
22,998 |
$163K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
5,151 |
4,229 |
$124K |
| 92507 |
Treatment of speech, language, voice, communication, and/or auditory processing disorder |
971 |
308 |
$119K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
1,278 |
424 |
$119K |
| 87631 |
|
1,243 |
1,024 |
$115K |
| 36415 |
Collection of venous blood by venipuncture |
41,835 |
33,826 |
$96K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
428 |
386 |
$79K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
7,816 |
6,271 |
$54K |
| 11042 |
Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm |
154 |
63 |
$52K |
| 70450 |
Computed tomography, head or brain; without contrast material |
401 |
302 |
$38K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
10,026 |
8,197 |
$37K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
375 |
108 |
$36K |
| 81001 |
|
20,581 |
17,795 |
$35K |
| G0378 |
Hospital observation service, per hour |
172 |
56 |
$29K |
| 84484 |
|
3,258 |
2,474 |
$27K |
| 94060 |
|
416 |
337 |
$27K |
| 84703 |
|
4,567 |
3,954 |
$24K |
| 83690 |
|
6,502 |
5,624 |
$23K |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
428 |
386 |
$21K |
| 73630 |
|
482 |
412 |
$20K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
106 |
101 |
$19K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
445 |
402 |
$18K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
650 |
568 |
$14K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
811 |
407 |
$13K |
| 95819 |
|
29 |
27 |
$11K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
231 |
196 |
$11K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
501 |
374 |
$10K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
109 |
99 |
$10K |
| 83970 |
|
192 |
183 |
$7K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
244 |
231 |
$6K |
| 85027 |
|
1,086 |
839 |
$4K |
| 97112 |
Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination |
194 |
53 |
$4K |
| 84425 |
|
190 |
181 |
$4K |
| 93976 |
|
13 |
13 |
$3K |
| 83735 |
|
725 |
596 |
$3K |
| 84443 |
Thyroid stimulating hormone (TSH) |
216 |
205 |
$3K |
| 81025 |
|
799 |
695 |
$3K |
| 87807 |
|
204 |
114 |
$3K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
1,764 |
1,518 |
$3K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
315 |
270 |
$3K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
93 |
77 |
$3K |
| 82607 |
|
192 |
183 |
$3K |
| 80061 |
Lipid panel |
214 |
203 |
$3K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
70 |
60 |
$2K |
| 71250 |
|
13 |
13 |
$2K |
| 83525 |
|
192 |
183 |
$2K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
105 |
75 |
$2K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
38 |
35 |
$2K |
| 72100 |
|
31 |
31 |
$2K |
| 87536 |
|
51 |
40 |
$2K |
| 84439 |
|
191 |
182 |
$2K |
| 83550 |
|
190 |
181 |
$1K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
204 |
195 |
$1K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
55 |
52 |
$1K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
55 |
52 |
$1K |
| 87081 |
|
261 |
221 |
$1K |
| 85730 |
|
272 |
229 |
$1K |
| 83540 |
|
190 |
181 |
$1K |
| 83605 |
|
235 |
189 |
$1K |
| 85610 |
|
273 |
230 |
$881.15 |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
28 |
28 |
$870.00 |
| 83880 |
|
27 |
26 |
$614.90 |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
170 |
143 |
$550.86 |
| 86360 |
|
34 |
26 |
$529.99 |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
14 |
14 |
$456.17 |
| 86359 |
|
34 |
26 |
$425.62 |
| 82248 |
|
117 |
99 |
$398.47 |
| 84550 |
|
100 |
94 |
$392.07 |
| J7030 |
Infusion, normal saline solution , 1000 cc |
2,287 |
2,046 |
$391.04 |
| 94729 |
|
125 |
96 |
$381.90 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
2,310 |
1,919 |
$255.74 |
| 99000 |
|
137 |
104 |
$201.64 |
| 99001 |
|
81 |
61 |
$59.28 |
| 86850 |
|
12 |
12 |
$39.08 |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
209 |
186 |
$0.00 |
| J0665 |
Injection, bupivicaine, not otherwise specified, 0.5 mg |
190 |
109 |
$0.00 |
| 94726 |
|
125 |
96 |
$0.00 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
17 |
13 |
$0.00 |
| J1596 |
Injection, glycopyrrolate, 0.1 mg |
30 |
26 |
$0.00 |
| 0202U |
Oncology (prostate), multianalyte, gene expression profiling |
17 |
17 |
$0.00 |
| J2704 |
Injection, propofol, 10 mg |
510 |
443 |
$0.00 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
636 |
567 |
$0.00 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
241 |
206 |
$0.00 |
| J0690 |
Injection, cefazolin sodium, 500 mg |
172 |
157 |
$0.00 |
| J1170 |
Injection, hydromorphone, up to 4 mg |
56 |
42 |
$0.00 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
49 |
40 |
$0.00 |
| 96376 |
|
36 |
13 |
$0.00 |